2016
Padma 28 for intermittent claudication
Abstract: Some evidence exists from individual trials to suggest that Padma 28 may be effective in increasing walking distances, at least in the short term (four months), in people with IC. Side effects do not appear to be a problem. However, the longer term effects of treatment are unknown and the clinical significance of the improvements in walking distance are questionable. Moreover, the quality of the evidence is limited by the small sample size of the available trials, limited reporting of statistical analyses that…
Search citation statements
Paper Sections
Select...
6
1
0
0
Citation Types
1
3
0
0
Year Published
Range
2016
2022
Publication Types
Select...
5
1
1
Relationship
0
7
Authors
Journals
Cited by 7 publications
(4 citation statements)
References 27 publications
1
3
0
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…As stated before, we also found a slight rise of ICD in placebo-treated controls; several studies reported in other reviews 33,69 show a slight increment in patients treated with placebo, which refers to improvement in the lifestyle or in the physical activities of the patients when assessed for confounders; 27,70 this was particularly evident when the placebo group went through supervised and personalized physical activity programmes 26,71 or the optimization of concomitant treatments.…”
Section: Results
supporting
confidence: 83%